Form 10-Q · Quarterly report
HCA Healthcare 10-Q, filed Jul 28, 2026
- Filed
- CIK
- 0000860730
- Accession no.
- 0001193125-26-321077
Summary
HCA Healthcare repurchased 4,752,930 common shares during the quarter ended June 30, 2026, at an average price of $414.25, leaving $7.210 billion available under its January 2026 repurchase authorization, and declared a quarterly dividend of $0.78 per share payable September 30, 2026. HCA's management concluded its disclosure controls and procedures were effective as of June 30, 2026.
Key points
- Second-quarter 2026 emergency room visits were 2,526,147, outpatient surgeries were 246,947, and inpatient surgeries were 133,041.
- Days revenues in accounts receivable were 55 in the second quarter of 2026, and outpatient revenues were 34% of patient revenues.
- HCA's board declared a quarterly dividend of $0.78 per share payable September 30, 2026, to stockholders of record on September 16, 2026.
- No director or officer adopted or terminated a Rule 10b5-1 trading arrangement during the quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued) 2026 2025 Emergency room visits(g): Quarter: First 2,509,083 2,518,716 Second 2,526,147 2,439,763 Third 2,477,474 Fourth 2,511,009 Year 9,946,962 Outpatient surgeries(h): Quarter: First 240,061 246,620 Second 246,947 258,365 Third 253,426 Fourth 264,401 Year 1,022,812 Inpatient surgeries(i): Quarter: First 133,262 133,759 Second 133,041 136,122 Third 138,563 Fourth 136,961 Year 545,405 Days revenues in accounts receivable(j): Quarter: First 53 54 Second 55 51 Third 50 Fourth 51 Outpatient revenues as a % of patient revenues(k): Quarter: First 37 % 37 % Second 34 % 38 % Third 38 % Fourth…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.